European Commission: Consultation on Stakeholder Participation In HTA Network

Posted 09 May 2012 | By Louise Zornoza 

The European Commission is requesting input from stakeholders, including drug and device companies, as to "how the consultation with stakeholders in the Health Technology Assessment (HTA) network's activities could be facilitated." 

An "informal" HTA network of member state entities that conduct relative effectiveness work-such as the UK's NICE and Germany's IQWiG-was mandated in 2011 "to support collaboration between Member States in developing and sharing methodologies for health technology assessment including relative effectiveness assessment (Article 15 of Directive 2011/4)."

The Directive also requires stakeholder participation in "the work of the network."

Read more:

European Commission - Public consultation on the modalities of stakeholder consultation in the voluntary Health Technology Assessment network to be established under Directive 2011/24/EU

Read more Breaking News from RegLinks

Regulatory Focus newsletters

All the biggest regulatory news and happenings.


Most Viewed Articles